Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01104493 · ClinicalTrials.gov registry record · Phase 4
A Clinical Study to Assess the Safety of a New Influenza Vaccine
A Phase 4 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT01104493 is a Phase 4 study that has completed, run by MedImmune. The registered enrollment target is 300 participants.
The verdict
NCT01104493, a Phase 4 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
To assess the safety of a new influenza virus vaccine containing a new virus strain in healthy patients prior to the release of the vaccine.
Interventions
- OTHER Placebo
- BIOLOGICAL Monovalent Frozen FluMist®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01104493
The ClinicalTrials.gov registry entry for NCT01104493 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01104493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01104493 about?
NCT01104493 is a clinical study titled "A Clinical Study to Assess the Safety of a New Influenza Vaccine". To assess the safety of a new influenza virus vaccine containing a new virus strain in healthy patients prior to the release of the vaccine.
What is the current status of trial NCT01104493?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2010-05. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01104493?
The interventions under investigation include: Placebo (OTHER), Monovalent Frozen FluMist® (BIOLOGICAL).
Who is sponsoring clinical trial NCT01104493?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.